Lisa Wisniewski, PhD - President and Managing Partner
Lisa Wisniewski is a drug development executive and thought leader whose scientific, regulatory, operational and business experience uniquely positions her to assess, develop and optimize pharmaceutical strategy. She has over 20 years of global experience driving the development and execution of pharmaceutical strategy, developing and leading teams and transformations that have delivered significant results in multiple therapeutic areas including oncology, anti-infectives, and vaccines. Lisa’s experience includes large and small molecules and devices in all research and development phases.
In 2014, Lisa founded S3B to help biotech companies translate their science into drug development strategy. Since S3B’s inception, she has guided multiple startups as they selected their lead indication and developed their business plan in support of their fund raising activities resulting in increased interest in the asset. As an Executive in Residence at Mount Sinai Innovation Partners she works with the Inventor and the Licensing Director to identify those activities that will address key areas of development risk thus improving the value of the technology.